Item 5.07 Submission of Matters to a Vote of Security Holders.

On December 23, 2020, Ocugen, Inc. (the "Company") held its 2020 Annual Meeting of Stockholders (the "Annual Meeting") virtually. The Annual Meeting was adjourned until January 13, 2021 (the "Adjourned Portion") solely with respect to the voting on Item 2 ("Item 2"), the approval and adoption of an amendment to the Company's Sixth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock, par value $0.01 (the "Common Stock"). On December 23, 2020, the Company filed an amendment to its Definitive Proxy Statement filed on October 30, 2020 on Form DEFR 14A, which amended and restated Item 2 by decreasing the proposed aggregate number of shares of our Common Stock that would be authorized to be issued from 500,000,000 shares to 400,000,000 shares. On January 12, 2021, the Board of Directors of the Company (the "Board") determined to withdraw Item 2 from stockholder consideration. As a result, the Board determined to cancel the reconvening of the Adjourned Portion of the Annual Meeting. All other items set forth in the Definitive Proxy Statement were submitted to stockholder vote at the Company's annual meeting of stockholders on December 23, 2020, as reported on the Company's Form 8-K filed with the Securities and Exchange Commission on December 28, 2020.

© Edgar Online, source Glimpses